• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板单采术对校正血小板计数增加值的影响。

The impact of apheresis platelet manipulation on corrected count increment.

机构信息

Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21287, USA.

出版信息

Transfusion. 2012 Jun;52(6):1221-7. doi: 10.1111/j.1537-2995.2011.03476.x. Epub 2012 Jan 10.

DOI:10.1111/j.1537-2995.2011.03476.x
PMID:22233358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3325359/
Abstract

BACKGROUND

Concentrating and washing apheresis platelets (APs) substantially reduce the number of allergic transfusion reactions likely due to removal of plasma. However, these processes may damage platelets (PLTs). This study evaluated whether concentrating or washing APs decrease the corrected count increment (CCI).

STUDY DESIGN AND METHODS

This retrospective study evaluated individuals who initially received unmanipulated APs and subsequently received concentrated and/or washed APs at a large university hospital between 1998 and 2009. Concentrated units were prepared by reducing the plasma volume of APs by a goal of more than 67%. Washed units were prepared by washing the APs with 1 L of normal saline. The CCI (PLTs [×10(6)] × m(2)/L) for all transfusions was calculated. Hypothesis testing was performed with t tests for continuous variables and chi-square tests for dichotomous variables.

RESULTS

We evaluated 121 individuals: 46 patients who received unmanipulated, concentrated, and then washed APs; 59 patients who received unmanipulated and then concentrated APs; and 16 patients who received unmanipulated and then washed APs. Patient demographics were similar among the three groups. The mean CCI for unmanipulated AP transfusions at 0 to 2 hours posttransfusion was significantly higher than concentrated and washed PLT transfusions (p<0.001). When accounting for PLT loss due to manipulation, concentrating APs did not impact the CCI. However, the CCI remained significantly lower for washed products at all time points after transfusion (40.7% mean reduction at 20-24 hr, p<0.001).

CONCLUSIONS

Washing APs significantly reduces PLT count recovery and survival, as demonstrated by a significantly reduced CCI.

摘要

背景

浓缩和洗涤单采血小板(APs)可大大减少因去除血浆而引起的过敏输血反应的数量。然而,这些过程可能会损伤血小板(PLTs)。本研究评估了浓缩或洗涤 APs 是否会降低校正后的血小板计数增加(CCI)。

研究设计和方法

本回顾性研究评估了 1998 年至 2009 年期间在一家大型大学医院中,最初接受未处理的 APs 后,随后接受浓缩和/或洗涤 APs 的个体。浓缩单位通过将 APs 的血浆体积减少到目标值的 67%以上来制备。洗涤单位通过用 1 L 生理盐水洗涤 APs 来制备。所有输血的 CCI(血小板[×10(6)]×m(2)/L)都进行了计算。连续变量采用 t 检验,二分类变量采用卡方检验进行假设检验。

结果

我们评估了 121 名患者:46 名患者接受了未处理的、浓缩的和随后洗涤的 APs;59 名患者接受了未处理的浓缩的 APs;16 名患者接受了未处理的洗涤的 APs。三组患者的人口统计学特征相似。未处理的 AP 输血后 0 至 2 小时的平均 CCI 明显高于浓缩和洗涤的 PLT 输血(p<0.001)。当考虑到由于操作导致的 PLT 损失时,浓缩 APs 并不影响 CCI。然而,在输血后所有时间点,洗涤产品的 CCI 仍然明显降低(20-24 小时时平均降低 40.7%,p<0.001)。

结论

洗涤 APs 显著降低了 PLT 计数的恢复和存活率,这表现为 CCI 显著降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f2/3325359/d993324c4bc0/nihms343491f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f2/3325359/d993324c4bc0/nihms343491f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f2/3325359/d993324c4bc0/nihms343491f1.jpg

相似文献

1
The impact of apheresis platelet manipulation on corrected count increment.血小板单采术对校正血小板计数增加值的影响。
Transfusion. 2012 Jun;52(6):1221-7. doi: 10.1111/j.1537-2995.2011.03476.x. Epub 2012 Jan 10.
2
The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).血小板添加剂溶液单采血小板对过敏输血反应和校正计数增加(CME)的影响。
Transfusion. 2014 Jun;54(6):1523-9; quiz 1522. doi: 10.1111/trf.12498. Epub 2013 Nov 19.
3
Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction.通过减少血浆来预防血小板和红细胞的过敏输血反应。
Transfusion. 2011 Aug;51(8):1676-83. doi: 10.1111/j.1537-2995.2010.03008.x. Epub 2011 Jan 7.
4
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
5
A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.体积减少型与标准 HLA/HPA 配型血小板在同种免疫成年患者中的比较。
Transfusion. 2012 Apr;52(4):742-51. doi: 10.1111/j.1537-2995.2011.03364.x. Epub 2011 Oct 7.
6
Splitting apheresis platelets as a contingency measure for inventory shortages.拆分单采血小板作为库存短缺时的应急措施。
Transfusion. 2024 Dec;64(12):2222-2227. doi: 10.1111/trf.18055. Epub 2024 Nov 6.
7
ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.ABO 抗体效价不能预测由于血浆不相容的血小板输注引起的溶血性反应。
Transfusion. 2012 Oct;52(10):2087-93. doi: 10.1111/j.1537-2995.2012.03574.x. Epub 2012 Feb 17.
8
Platelet corrected count increments by apheresis platform.通过单采术平台的血小板校正计数增量。
Transfusion. 2016 Oct;56(10):2584-2586. doi: 10.1111/trf.13788. Epub 2016 Aug 29.
9
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.一项评价经 MIRASOL 病原体灭活技术处理的血小板的性能和安全性的随机对照临床试验。
Transfusion. 2010 Nov;50(11):2362-75. doi: 10.1111/j.1537-2995.2010.02694.x.
10
Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.使用体外出血时间和输注血小板校正计数增加值评估血小板功能。比较来自混合白膜层和单采血小板的浓缩血小板。
Vox Sang. 1996;70(2):69-75. doi: 10.1111/j.1423-0410.1996.tb01296.x.

引用本文的文献

1
What Laboratory Tests and Physiologic Triggers Should Guide the Decision to Administer a Platelet or Plasma Transfusion in Critically Ill Children and What Product Attributes Are Optimal to Guide Specific Product Selection? From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.哪些实验室检测和生理触发因素应指导危重症儿童输注血小板或血浆的决策,以及哪些产品特性最有利于指导特定产品的选择?来自输血和贫血专家倡议-控制/避免出血。
Pediatr Crit Care Med. 2022 Jan 1;23(13 Suppl 1 1S):e1-e13. doi: 10.1097/PCC.0000000000002854.
2
Comparison of Quality and Efficacy of Apheresis Platelets Stored in Platelet Additive Solution Vis a Vis Plasma.血小板添加剂溶液与血浆中储存的单采血小板的质量和疗效比较
Indian J Hematol Blood Transfus. 2021 Oct;37(4):648-657. doi: 10.1007/s12288-021-01408-x. Epub 2021 Mar 12.
3

本文引用的文献

1
Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.在去白细胞血小板产品中的变应原与过敏输血反应有关。
Transfusion. 2012 Mar;52(3):575-81. doi: 10.1111/j.1537-2995.2011.03310.x. Epub 2011 Aug 29.
2
Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.受者的特应性在过敏输血反应中对单采血小板的影响。
Transfusion. 2011 Nov;51(11):2337-42. doi: 10.1111/j.1537-2995.2011.03160.x. Epub 2011 May 13.
3
Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.
Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study.危重症患者血小板输注无效的患病率、危险因素及结局:一项回顾性队列研究
Crit Care Res Pract. 2021 Sep 23;2021:5589768. doi: 10.1155/2021/5589768. eCollection 2021.
4
Does ABO and RhD matching matter for platelet transfusion?ABO 和 RhD 配型对血小板输注重要吗?
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):512-517. doi: 10.1182/hematology.2020000135.
5
Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.使用血小板添加剂溶液进行质量改进,以实现更安全的非同型血小板输注。
Immunohematology. 2019 Sep;35(3):108-115.
6
Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.儿科危重病输血和贫血专业知识倡议:儿科患者 RBC 成分选择和处理的建议。
Pediatr Crit Care Med. 2018 Sep;19(9S Suppl 1):S163-S169. doi: 10.1097/PCC.0000000000001625.
7
First Indian initiative for preparation of low-titer group "O" single-donor platelets with platelet additive solution.印度首次采用血小板添加剂溶液制备低滴度“O”型单供体血小板的举措。
Asian J Transfus Sci. 2018 Jan-Jun;12(1):10-16. doi: 10.4103/ajts.AJTS_2_17.
8
Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.用血小板添加剂溶液洗涤制备富含血小板的白细胞浓缩物的质量评估和输血效果。
Blood Transfus. 2018 May;16(3):273-278. doi: 10.2450/2017.0277-16. Epub 2017 Apr 13.
9
The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).血小板添加剂溶液单采血小板对过敏输血反应和校正计数增加(CME)的影响。
Transfusion. 2014 Jun;54(6):1523-9; quiz 1522. doi: 10.1111/trf.12498. Epub 2013 Nov 19.
10
The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.血小板添加剂溶液预防过敏输血反应的成本效益。
Transfusion. 2013 Nov;53(11):2609-18. doi: 10.1111/trf.12095. Epub 2013 Jan 30.
血小板过敏输血反应与受者和供者因素有关,而与产品属性关系不大。
Transfusion. 2011 Aug;51(8):1716-22. doi: 10.1111/j.1537-2995.2010.03009.x. Epub 2011 Jan 7.
4
Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction.通过减少血浆来预防血小板和红细胞的过敏输血反应。
Transfusion. 2011 Aug;51(8):1676-83. doi: 10.1111/j.1537-2995.2010.03008.x. Epub 2011 Jan 7.
5
A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal.比较洗涤和体积减少血小板在血小板活化、聚集和血浆蛋白去除方面的差异。
Transfusion. 2011 May;51(5):1030-6. doi: 10.1111/j.1537-2995.2010.02897.x. Epub 2010 Oct 4.
6
Dose of prophylactic platelet transfusions and prevention of hemorrhage.预防性血小板输血剂量与出血预防。
N Engl J Med. 2010 Feb 18;362(7):600-13. doi: 10.1056/NEJMoa0904084.
7
Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).通过去除血浆上清液并重新悬浮于新的添加剂溶液(M-sol)中来减少对血小板的不良反应。
Transfusion. 2009 Feb;49(2):214-8. doi: 10.1111/j.1537-2995.2008.01918.x. Epub 2008 Sep 16.
8
Transfusion premedications: a growing practice not based on evidence.输血前用药:一种缺乏证据支持却不断增加的做法。
Transfusion. 2007 Jun;47(6):1089-96. doi: 10.1111/j.1537-2995.2007.01242.x.
9
A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma.一项关于使用储存在血小板添加剂溶液II中的血小板与血浆进行输血疗效的多中心随机研究。
Blood. 2006 Nov 1;108(9):3210-5. doi: 10.1182/blood-2006-04-020131. Epub 2006 Jul 6.
10
Volume-reduced platelet concentrates.体积减少的血小板浓缩物。
Curr Hematol Rep. 2006 Mar;5(1):82-8.